Tenon Medical, Inc.
TNONWDrugs in Pipeline
4
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
intrapleural irrigation
Therapy
Spacing of Eculizumab infusions
Hemolytic-Uremic Syndrome, Atypical
triple therapy
HIV
Arikayce
Mycobacterium; Xenopi
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
intrapleural irrigation | Phase 3 | Therapy | - | - |
Spacing of Eculizumab infusions | Phase 3 | Hemolytic-Uremic Syndrome, Atypical | - | - |
triple therapy | Phase 3 | HIV | - | - |
Arikayce | Phase 2 | Mycobacterium; Xenopi | - | - |
Frequently asked questions
What is in Tenon Medical, Inc.'s drug pipeline?→
CatalystAlert tracks 4 drug candidates in Tenon Medical, Inc.'s (TNONW) pipeline across Phase 3, Phase 2. Its lead program is intrapleural irrigation (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Tenon Medical, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Tenon Medical, Inc. (TNONW) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track TNONW biotech catalysts?→
Add TNONW to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Tenon Medical, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.